Apabetalone (RVX-208) reduces vascular inflammation in vitro and in CVD patients by a BET-dependent epigenetic mechanism
Apabetalone (RVX-208) 通过 BET 依赖的表观遗传机制减轻体外和 CVD 患者的血管炎症
期刊:Clinical Epigenetics
影响因子:
doi:10.1186/s13148-019-0696-z
Laura M Tsujikawa, Li Fu, Shovon Das, Christopher Halliday, Brooke D Rakai, Stephanie C Stotz, Christopher D Sarsons, Dean Gilham, Emily Daze, Sylwia Wasiak, Deborah Studer, Kristina D Rinker, Michael Sweeney, Jan O Johansson, Norman C W Wong, Ewelina Kulikowski